Literature DB >> 2824681

Hepatitis B virus (HBV)-DNA-positive hepatocellular carcinoma following hepatitis B virus infection in a child.

R Giacchino1, P Pontisso, C Navone, A Alberti, G Dini, F Facco, B Ciravegna.   

Abstract

Integrated hepatitis B virus (HBV) DNA sequences were found in neoplastic liver tissue of a hepatitis B surface antigen (HBsAg)-negative child who had previously suffered from HBsAg-positive chronic active hepatitis and was anti-HBs and anti-hepatitis B core (HBc) positive at the time of tumor development. Reintegration pattern was consistent with the presence of a single integration site of the HBV genome into cellular DNA, and clonal proliferation of such infected cells. A normal liver, tested in the same experiment with the same amount of total DNA, was negative for viral DNA sequences. These findings support the possible oncogenic role of HBV in the development of liver cancer, not only in adults, but also in children, even in patients who are negative for HBsAg at the time of tumor diagnosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824681     DOI: 10.1002/jmv.1890230207

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  HBV-DNA-related hepatocellular carcinoma occurring in childhood. Report of three cases.

Authors:  R Giacchino; C Navone; F Facco; G Giambartolomei; P Pontisso; F Callea
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

2.  Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.

Authors:  Y S White; P J Johnson; F Davison; R Williams
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

3.  Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.

Authors:  Hitoshi Tajiri; Tomoko Takano; Hideo Tanaka; Kosuke Ushijima; Ayano Inui; Yoko Miyoshi; Keiichi Ozono; Daiki Abukawa; Takeshi Endo; Stephen Brooks; Yasuhito Tanaka
Journal:  Cancer Med       Date:  2016-10-17       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.